CD226 and melanoma: Similar results were obtained with this combination approach in a B16 melanoma mouse model, where NK cell-specific TIGIT-deficiency resulted in the upregulation of DNAM-1 (CD226) expression by tumor-infiltrating NK cells and in tumor growth inhibition in CD155-deficient mice [124].